SCHEMBL30482155

SCHEMBL30482155

Fc1ccc(CNCc2ccccc2)nc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
TDP1 Q9NUW8 1/20 0.44
ALDH1A1 P00352 4/20 0.43
KDM4E B2RXH2 3/20 0.43
BCHE P06276 1/20 0.42
LMNA P02545 3/20 0.42
MAPK1 P28482 3/20 0.42
MAPT P10636 1/20 0.42
XBP1 P17861 1/20 0.42
HTT P42858 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
KDM4A O75164 1/20 0.41
KDM4B O94953 1/20 0.41
KDM5C P41229 1/20 0.41
KDM5B Q9UGL1 1/20 0.41
PLA2G1B P04054 1/20 0.41
ATG4B Q9Y4P1 1/20 0.41
TP53 P04637 1/20 0.40
GAA P10253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25376070 1.00 MEN1 (0.44) MEN1KMT2ATDP1ALDH1A1KDM4E
SCHEMBL25373983 0.79 MEN1 (0.44) MEN1KMT2ATDP1ALDH1A1BCHE
SCHEMBL25375347 0.79 HTR1A (0.45) MEN1KMT2ATDP1ALDH1A1KDM4E
SCHEMBL25376336 0.79 KDM1A (0.54) MEN1KMT2ATDP1ALDH1A1KDM4E
SCHEMBL25376161 0.78 KDM4E (0.52) MEN1KMT2AALDH1A1KDM4ELMNA
SCHEMBL31453224 0.77 MAOA (0.58) ALDH1A1LMNAMAPTTP53L3MBTL1
SCHEMBL1038941 0.77 LMNA (0.65) MEN1KMT2ATDP1ALDH1A1KDM4E
SCHEMBL18843420 0.77 KDM4A (0.43) MEN1KMT2ATDP1ALDH1A1BCHE
SCHEMBL19865686 0.77 MCHR1 (0.39) KDM4ELMNAMAPK1GAA
SCHEMBL25380114 0.76 KDM1A (0.52) MEN1KMT2ATDP1ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4469438-A1 COMPOUNDS AND METHODS OF USE Tango Therapeutics, Inc. (US) 2024-12-04 EP disclosed
WO-2023146987-A1 COMPOUNDS AND METHODS OF USE TANGO THERAPEUTICS, INC. (US) 2023-08-03 WO disclosed